Sphinganine

Sphinganine is a lipid of Sphingolipids (SP) class. Sphinganine is associated with abnormalities such as Sphingolipidoses, CLEFT LIP, CONGENITAL HEALED, Aortic aneurysm, familial thoracic 4, Morphologically altered structure and Atherosclerosis. The involved functions are known as Transcription, Genetic, Signal, Muscle Contraction, biological adaptation to stress and Gene Expression. Sphinganine often locates in Tissue membrane, Membrane, Protoplasm, Plasma membrane and Cytoplasmic. The associated genes with Sphinganine are SLC33A1 gene, HM13 gene, P4HTM gene, SPHK1 gene and SPHK2 gene. The related lipids are Sphingolipids, Phosphatidylserines, Sterols, Fatty Acids and inositolphosphorylceramide. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of Sphinganine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphinganine?

Sphinganine is suspected in Pulmonary Edema, Morphologically altered structure, Infection, HIV Infections, Pulmonary Hypertension, Exanthema and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphinganine

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Swine Diseases D013553 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with Sphinganine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphinganine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphinganine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphinganine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphinganine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphinganine?

Knock-out

Knock-out are used in the study 'Sphingolipids are required for the stable membrane association of glycosylphosphatidylinositol-anchored proteins in yeast.' (Watanabe R et al., 2002) and Knock-out are used in the study 'Role for de novo sphingoid base biosynthesis in the heat-induced transient cell cycle arrest of Saccharomyces cerevisiae.' (Jenkins GM and Hannun YA, 2001).

Mouse Model

Mouse Model are used in the study 'Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity.' (Hu W et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphinganine

Download all related citations
Per page 10 20 50 100 | Total 790
Authors Title Published Journal PubMed Link
Touboul D et al. Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease. 2005 Anal Bioanal Chem pmid:15959771
Kariya Y et al. Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis. 2005 Genes Cells pmid:15938718
Alkan S et al. Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. 2005 Am. J. Hematol. pmid:15929099
Osuchowski MF et al. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: implication of blood brain barrier. 2005 Food Chem. Toxicol. pmid:15913876
Yoo HS et al. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. 1992 Toxicol. Appl. Pharmacol. pmid:1585377
Hsiao SH et al. Effects of exogenous sphinganine, sphingosine, and sphingosine-1-phosphate on relaxation and contraction of porcine thoracic aortic and pulmonary arterial rings. 2005 Toxicol. Sci. pmid:15829618
He Q et al. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity. 2005 Food Chem. Toxicol. pmid:15811577
Cheek S et al. A comprehensive update of the sequence and structure classification of kinases. 2005 BMC Struct. Biol. pmid:15771780
Berdyshev EV et al. Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. 2005 Anal. Biochem. pmid:15766719
Ikeda M et al. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme. 2005 Biochem. Biophys. Res. Commun. pmid:15737611
Inagaki Y et al. Sphingosine 1-phosphate analogue recognition and selectivity at S1P4 within the endothelial differentiation gene family of receptors. 2005 Biochem. J. pmid:15733055
Nagahara Y et al. Phytosphingosine induced mitochondria-involved apoptosis. 2005 Cancer Sci. pmid:15723652
Budnik LT and Brunswig-Spickenheier B Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor. 2005 J. Lipid Res. pmid:15716590
Osuchowski MF et al. Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling. 2005 Neurotoxicology pmid:15713342
Vallée B and Riezman H Lip1p: a novel subunit of acyl-CoA ceramide synthase. 2005 EMBO J. pmid:15692566
Tran ST et al. Chronic effects of fumonisin B1 on ducks. 2005 Poult. Sci. pmid:15685938
Fernández-Surumay G et al. Glucose reaction with fumonisin B1 partially reduces its toxicity in swine. 2004 J. Agric. Food Chem. pmid:15675827
Coursol S et al. Arabidopsis sphingosine kinase and the effects of phytosphingosine-1-phosphate on stomatal aperture. 2005 Plant Physiol. pmid:15665242
Sugawara T et al. Efflux of sphingoid bases by P-glycoprotein in human intestinal Caco-2 cells. 2004 Biosci. Biotechnol. Biochem. pmid:15618625
Górska M et al. Concentrations of sphingosine and sphinganine in plasma of patients with type 2 diabetes. 2005 Med. Sci. Monit. pmid:15614193
Sharma N et al. Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells. 2004 Chem. Biol. Interact. pmid:15607760
He Q et al. Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride. 2005 Toxicology pmid:15590129
Rentz SS et al. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells. 2005 Food Chem. Toxicol. pmid:15582204
Houjou T et al. Rapid and selective identification of molecular species in phosphatidylcholine and sphingomyelin by conditional neutral loss scanning and MS3. 2004 Rapid Commun. Mass Spectrom. pmid:15565732
Wang JP et al. Stimulation of cellular free Ca2+ elevation and inhibition of store-operated Ca2+ entry by kazinol B in neutrophils. 2004 Naunyn Schmiedebergs Arch. Pharmacol. pmid:15558242
Lee WJ et al. Sphingosine mediates FTY720-induced apoptosis in LLC-PK1 cells. 2004 Exp. Mol. Med. pmid:15557814
Grimm C et al. Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected]. 2005 Mol. Pharmacol. pmid:15550678
Becker KP et al. Selective inhibition of juxtanuclear translocation of protein kinase C betaII by a negative feedback mechanism involving ceramide formed from the salvage pathway. 2005 J. Biol. Chem. pmid:15546881
Park TS et al. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. 2004 Circulation pmid:15545514
Yu MU et al. Altered de novo sphingolipid biosynthesis is involved in the serum deprivation-induced cell death in LLC-PK1 cells. 2004 J. Toxicol. Environ. Health Part A pmid:15513905
Rehman F et al. Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity. 2004 Br. J. Cancer pmid:15505623
Gopee NV and Sharma RP The mycotoxin fumonisin B1 transiently activates nuclear factor-kappaB, tumor necrosis factor alpha and caspase 3 via protein kinase Calpha-dependent pathway in porcine renal epithelial cells. 2004 Cell Biol. Toxicol. pmid:15499968
Sharma N et al. Augmented fumonisin B1 toxicity in co-cultures: evidence for crosstalk between macrophages and non-parenchymatous liver epithelial cells involving proinflammatory cytokines. 2004 Toxicology pmid:15363598
Tardieu D et al. Toxicity of maize containing known levels of fumonisin B1 during force-feeding of ducks. 2004 Poult. Sci. pmid:15339002
Kihara A and Igarashi Y FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an active site that faces the cytosolic side of the endoplasmic reticulum membrane. 2004 J. Biol. Chem. pmid:15328338
Katoh N Inhibition by sulfatide of 21-kDa protein phosphorylation by protein kinase C in cow mammary gland and its reversal by phosphatidylserine. 2004 J. Vet. Med. Sci. pmid:15297754
Johnson VJ et al. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations. 2004 Toxicology pmid:15297021
Batra S et al. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. 2004 Cancer Res. pmid:15289350
Van IJzendoorn SC et al. Polarized membrane traffic and cell polarity development is dependent on dihydroceramide synthase-regulated sphinganine turnover. 2004 Mol. Biol. Cell pmid:15229289
Dobrzyń A et al. Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat. 2004 J. Physiol. Pharmacol. pmid:15213354
Kaneider NC et al. The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor. 2004 FASEB J. pmid:15208267
He Q et al. Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver. 2004 Mycopathologia pmid:15180163
Williams LD et al. Fumonisin-ortho-phthalaldehyde derivative is stabilized at low temperature. 2004 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:15171945
van der Westhuizen L et al. Disruption of sphingolipid biosynthesis in hepatocyte nodules: selective proliferative stimulus induced by fumonisin B1. 2004 Toxicology pmid:15158565
Bae JH et al. Cloning and functional characterization of the SUR2/SYR2 gene encoding sphinganine hydroxylase in Pichia ciferrii. 2004 Yeast pmid:15116344
So RC et al. Straightforward synthesis of sphinganines via a serine-derived Weinreb amide. 2004 J. Org. Chem. pmid:15104474
He Q et al. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases. 2004 Toxicol. Sci. pmid:15103051
Mizutani Y et al. Identification of the human sphingolipid C4-hydroxylase, hDES2, and its up-regulation during keratinocyte differentiation. 2004 FEBS Lett. pmid:15063729
Abbey-Hosch SE et al. Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B). 2004 Hypertension pmid:15037564
Tserng KY and Griffin RL Ceramide metabolite, not intact ceramide molecule, may be responsible for cellular toxicity. 2004 Biochem. J. pmid:14998372